These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 28932176)

  • 1. Effect of UDP-Glucuronosyltransferase (UGT) 1A Polymorphism (rs8330 and rs10929303) on Glucuronidation Status of Acetaminophen.
    Mehboob H; Tahir IM; Iqbal T; Saleem S; Perveen S; Farooqi A
    Dose Response; 2017; 15(3):1559325817723731. PubMed ID: 28932176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The UDP-glucuronosyltransferase (UGT) 1A polymorphism c.2042C>G (rs8330) is associated with increased human liver acetaminophen glucuronidation, increased UGT1A exon 5a/5b splice variant mRNA ratio, and decreased risk of unintentional acetaminophen-induced acute liver failure.
    Court MH; Freytsis M; Wang X; Peter I; Guillemette C; Hazarika S; Duan SX; Greenblatt DJ; Lee WM;
    J Pharmacol Exp Ther; 2013 May; 345(2):297-307. PubMed ID: 23408116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic polymorphism of UDP-glucuronosyltransferase (UGT2B15) and glucuronidation of paracetamol in healthy population.
    Mehboob H; Iqbal T; Jamil A; Khaliq T
    Pak J Pharm Sci; 2016 May; 29(3 Suppl):1037-41. PubMed ID: 27383482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucuronidation of acetaminophen is independent of UGT1A1 promotor genotype.
    Rauchschwalbe SK; Zühlsdorf MT; Wensing G; Kuhlmann J
    Int J Clin Pharmacol Ther; 2004 Feb; 42(2):73-7. PubMed ID: 15180166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interindividual variability in acetaminophen glucuronidation by human liver microsomes: identification of relevant acetaminophen UDP-glucuronosyltransferase isoforms.
    Court MH; Duan SX; von Moltke LL; Greenblatt DJ; Patten CJ; Miners JO; Mackenzie PI
    J Pharmacol Exp Ther; 2001 Dec; 299(3):998-1006. PubMed ID: 11714888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and validation of microRNAs directly regulating the UDP-glucuronosyltransferase 1A subfamily enzymes by a functional genomics approach.
    Papageorgiou I; Court MH
    Biochem Pharmacol; 2017 Aug; 137():93-106. PubMed ID: 28433553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlations of UGT1A1 gene polymorphisms with onset and prognosis of non-small cell lung cancer.
    Han ZF; Lin ST; Zhong M; Yu DJ
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):9973-9980. PubMed ID: 33090402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of acetaminophen glucuronidation by UDP-glucuronosyltransferases 1A1, 1A6, 1A9 and 2B15. Potential implications in acetaminophen-induced hepatotoxicity.
    Mutlib AE; Goosen TC; Bauman JN; Williams JA; Kulkarni S; Kostrubsky S
    Chem Res Toxicol; 2006 May; 19(5):701-9. PubMed ID: 16696573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue distribution and interindividual variation in human UDP-glucuronosyltransferase activity: relationship between UGT1A1 promoter genotype and variability in a liver bank.
    Fisher MB; Vandenbranden M; Findlay K; Burchell B; Thummel KE; Hall SD; Wrighton SA
    Pharmacogenetics; 2000 Nov; 10(8):727-39. PubMed ID: 11186135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human UDP-glucuronosyltransferase 1A1 is the primary enzyme responsible for the N-glucuronidation of N-hydroxy-PhIP in vitro.
    Malfatti MA; Felton JS
    Chem Res Toxicol; 2004 Aug; 17(8):1137-44. PubMed ID: 15310245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo glucuronidation activity of drugs in neonates: extensive interindividual variability despite their young age.
    Allegaert K; Vanhaesebrouck S; Verbesselt R; van den Anker JN
    Ther Drug Monit; 2009 Aug; 31(4):411-5. PubMed ID: 19494793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotype-genotype correlation of in vitro SN-38 (active metabolite of irinotecan) and bilirubin glucuronidation in human liver tissue with UGT1A1 promoter polymorphism.
    Iyer L; Hall D; Das S; Mortell MA; Ramírez J; Kim S; Di Rienzo A; Ratain MJ
    Clin Pharmacol Ther; 1999 May; 65(5):576-82. PubMed ID: 10340924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of niflumic acid as a selective inhibitor of human liver microsomal UDP-glucuronosyltransferase 1A9: application to the reaction phenotyping of acetaminophen glucuronidation.
    Miners JO; Bowalgaha K; Elliot DJ; Baranczewski P; Knights KM
    Drug Metab Dispos; 2011 Apr; 39(4):644-52. PubMed ID: 21245288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of UGT1A1 gene variants, expression levels, and enzyme concentrations with 2,3,7,8-TCDD exposure in individuals exposed to Agent Orange/Dioxin.
    Van Quang H; Vuong NB; Trang BNL; Toan NL; Van Tong H
    Sci Rep; 2024 Feb; 14(1):3315. PubMed ID: 38332122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UDP-glucuronosyltransferase (UGT) 1A1 mainly contributes to the glucuronidation of trovafloxacin.
    Fujiwara R; Sumida K; Kutsuno Y; Sakamoto M; Itoh T
    Drug Metab Pharmacokinet; 2015 Feb; 30(1):82-8. PubMed ID: 25760534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of UDP-Glucuronosyltransferase Polymorphisms on Stable Warfarin Doses in Patients with Mechanical Cardiac Valves.
    An SH; Chang BC; Lee KE; Gwak HS
    Cardiovasc Ther; 2015 Dec; 33(6):324-8. PubMed ID: 26223945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UGT1A6 and UGT2B15 polymorphisms and acetaminophen conjugation in response to a randomized, controlled diet of select fruits and vegetables.
    Navarro SL; Chen Y; Li L; Li SS; Chang JL; Schwarz Y; King IB; Potter JD; Bigler J; Lampe JW
    Drug Metab Dispos; 2011 Sep; 39(9):1650-7. PubMed ID: 21666065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substrates.
    Fujiwara R; Nakajima M; Yamanaka H; Katoh M; Yokoi T
    Drug Metab Dispos; 2008 Feb; 36(2):361-7. PubMed ID: 17998297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterizing the effects of common UDP glucuronosyltransferase (UGT) 1A6 and UGT1A1 polymorphisms on cis- and trans-resveratrol glucuronidation.
    Iwuchukwu OF; Ajetunmobi J; Ung D; Nagar S
    Drug Metab Dispos; 2009 Aug; 37(8):1726-32. PubMed ID: 19406951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucuronidation of etoposide in human liver microsomes is specifically catalyzed by UDP-glucuronosyltransferase 1A1.
    Watanabe Y; Nakajima M; Ohashi N; Kume T; Yokoi T
    Drug Metab Dispos; 2003 May; 31(5):589-95. PubMed ID: 12695347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.